THSD7B and lung carcinoma: Only one article reported that mutation of THSD7B in patients inhibits cell death-related pathways, up-regulates cell invasion and metastasis pathways, and down-regulates immune response pathways, which ultimately leads to a poor prognosis in lung cancer (27).